The double barrier in bone marrow transplantation.
D000818:Animals; D000961:Antilymphocyte Serum / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology; D001792:Blood Platelets / Q000276:immunology; D001803:Blood Transfusion; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D003520:Cyclophosphamide / Q000494:pharmacology; D004285:Dogs; D005856:Germ-Free Life; D006084:Graft Rejection; D006086:Graft vs Host Disease / Q000276:immunology; D006087:Graft vs Host Reaction; D000882:Haplorhini; D006648:Histocompatibility; D006649:Histocompatibility Antigens; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects; D051379:Mice; D011828:Radiation Chimera; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D000970:Antineoplastic Agents; D006649:Histocompatibility Antigens; D003520:Cyclophosphamide